Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oncolytics Biotech has been granted a Canadian patent for the clearance of neoplastic cells from mixed cellular compositions using viruses.
Subscribe to our email newsletter
The patent describes methods of selectively removing cancer cells ex vivo from blood stem cells and other organs using various viruses including modified vaccinia viruses, herpes simplex viruses, parapoxviruses and adenoviruses.
Matt Coffey, chief scientific officer of Oncolytics, said: “This patent broadens coverage in the area of using other modified oncolytic viruses to purge contaminating cancer cells from stem cell preparations used for transplants.”